These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17888575)

  • 1. Epidemiology of neuropathic pain: can we use the screening tools?
    Bennett MI; Bouhassira D
    Pain; 2007 Nov; 132(1-2):12-3. PubMed ID: 17888575
    [No Abstract]   [Full Text] [Related]  

  • 2. Validation of the S-LANSS in the community setting.
    Weingarten TN; Watson JC; Hooten WM; Wollan PC; Melton LJ; Locketz AJ; Wong GY; Yawn BP
    Pain; 2007 Nov; 132(1-2):189-94. PubMed ID: 17869424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and testing of a neuropathic pain screening questionnaire: ID Pain.
    Portenoy R
    Curr Med Res Opin; 2006 Aug; 22(8):1555-65. PubMed ID: 16870080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agreement and correlation between the self-report leeds assessment of neuropathic symptoms and signs and Douleur Neuropathique 4 Questions neuropathic pain screening tools in subjects with low back-related leg pain.
    Walsh J; Rabey MI; Hall TM
    J Manipulative Physiol Ther; 2012; 35(3):196-202. PubMed ID: 22397741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening tools for neuropathic pain: are they adaptable in different languages and cultures?
    Attal N
    Pain Med; 2010 Jul; 11(7):985-6. PubMed ID: 20642726
    [No Abstract]   [Full Text] [Related]  

  • 6. Neuropathic pain: Definition, assessment and epidemiology.
    Bouhassira D
    Rev Neurol (Paris); 2019; 175(1-2):16-25. PubMed ID: 30385075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using screening tools to identify neuropathic pain.
    Bennett MI; Attal N; Backonja MM; Baron R; Bouhassira D; Freynhagen R; Scholz J; Tölle TR; Wittchen HU; Jensen TS
    Pain; 2007 Feb; 127(3):199-203. PubMed ID: 17182186
    [No Abstract]   [Full Text] [Related]  

  • 8. Can neuropathic screening tools be used as outcome measures?
    Searle RD; Bennett MI; Tennant A
    Pain Med; 2011 Feb; 12(2):276-81. PubMed ID: 21223498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and preliminary validation of the NePIQoL: a quality-of-life measure for neuropathic pain.
    Poole HM; Murphy P; Nurmikko TJ
    J Pain Symptom Manage; 2009 Feb; 37(2):233-45. PubMed ID: 18676118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative sensory testing in measurement of neuropathic pain phenomena and other sensory abnormalities.
    Backonja MM; Walk D; Edwards RR; Sehgal N; Moeller-Bertram T; Wasan A; Irving G; Argoff C; Wallace M
    Clin J Pain; 2009 Sep; 25(7):641-7. PubMed ID: 19692807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of pain and relative diagnostic performance of screening tools for neuropathic pain in cancer patients: A cross-sectional study.
    Pérez C; Sánchez-Martínez N; Ballesteros A; Blanco T; Collazo A; González F; Villoria J
    Eur J Pain; 2015 Jul; 19(6):752-61. PubMed ID: 25265909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of screening tools in diagnosing neuropathic pain.
    Mulvey MR; Bennett MI; Liwowsky I; Freynhagen R
    Pain Manag; 2014 May; 4(3):233-43. PubMed ID: 24953075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using quality improvement methodology to improve neuropathic pain screening and assessment in patients with cancer.
    Lavoie Smith EM; Bakitas MA; Homel P; Fadul C; Meyer L; Skalla K; Bookbinder M
    J Cancer Educ; 2009; 24(2):135-40. PubMed ID: 19431031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introduction: Recommendations for the diagnosis, assessment, and treatment of neuropathic pain.
    Dworkin RH
    Am J Med; 2009 Oct; 122(10 Suppl):S1-2. PubMed ID: 19801047
    [No Abstract]   [Full Text] [Related]  

  • 15. The neuropathic pain diagnosed with the grading system is different from pain defined with the definition of neuropathic pain.
    Toda K
    Pain Pract; 2011; 11(6):583-4. PubMed ID: 22060310
    [No Abstract]   [Full Text] [Related]  

  • 16. Quantitative sensory testing and mapping: a review of nonautomated quantitative methods for examination of the patient with neuropathic pain.
    Walk D; Sehgal N; Moeller-Bertram T; Edwards RR; Wasan A; Wallace M; Irving G; Argoff C; Backonja MM
    Clin J Pain; 2009 Sep; 25(7):632-40. PubMed ID: 19692806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of nociceptive versus neuropathic pain in older adults.
    Arnstein P
    Medsurg Nurs; 2012; 21(6):388-9. PubMed ID: 23477035
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pain audit as a tool to optimize pain treatment in hospital departments].
    Aggerholm-Pedersen N; Jespersen TW; Olsen PR; Zachariae B
    Ugeskr Laeger; 2013 May; 175(21):1491-5. PubMed ID: 23697567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of neuropathic pain in primary care.
    Haanpää ML; Backonja MM; Bennett MI; Bouhassira D; Cruccu G; Hansson PT; Jensen TS; Kauppila T; Rice AS; Smith BH; Treede RD; Baron R
    Am J Med; 2009 Oct; 122(10 Suppl):S13-21. PubMed ID: 19801048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnostic accuracy of brief screening questions for psychosocial risk factors of poor outcome from an episode of pain: A systematic review.
    Mirkhil S; Kent PM
    Clin J Pain; 2009 May; 25(4):340-8. PubMed ID: 19590484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.